Sunday, 9 March 2014

Ludwig researchers show that infecting just 1 tumor with a virus could boost the systemic effectiveness of cancer immunotherapy

A Ludwig Cancer Research study suggests that the clinical efficacy of checkpoint blockade, a powerful new strategy to harness the immune response to treat cancers, might be dramatically improved if combined with oncolytic virotherapy, an investigational intervention that employs viruses to destroy tumors. via Health News from Medical News Today Read More Here..


Lake forest health and fitness http://ift.tt/NMUsqI

No comments:

Post a Comment